Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medicare Rx “Debit Card” Will Fund $5 Bil. In Drug Purchases, CMS Estimates

Executive Summary

The Medicare discount card program will provide $2.4 bil. in federal funds to support drug purchases by low-income seniors during 2004, CMS estimates

You may also be interested in...



Merck Offers Free Drugs To Medicare Rx Debit Card Enrollees

Merck will offer its drugs free to low-income seniors who sign up for Medicare-endorsed discount cards, the company announced Feb. 12

Merck Offers Free Drugs To Medicare Rx Debit Card Enrollees

Merck will offer its drugs free to low-income seniors who sign up for Medicare-endorsed discount cards, the company announced Feb. 12

Medicare Card Plan Is “Loss Leader” For 2006, Ex-CMS Head Scully Says

Sixty-five companies have applied to sponsor a Medicare-endorsed "debit" card in 2004, former Centers for Medicare & Medicaid Services Administrator Tom Scully said Jan. 14 during a Lash Group/Medical Marketing Economics conference in Washington, D.C

Related Content

UsernamePublicRestriction

Register

GB150348

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel